Business Wire

BM3EAC Corp. Termination of Discussions Regarding Proposed Business Combination With Arkon Energy

Share

BM3EAC Corp. (the “Company”), a shell company incorporated under the laws of the Cayman Islands as an exempted company with limited liability and listed on Euronext Amsterdam, the regulated market operated by Euronext Amsterdam N.V., hereby announces the termination of the discussions with Arkon Energy Ohio LLC (now Arkon Energy US Holdco LLC) (“Arkon”) regarding a potential transaction, including a business combination, initially announced on 21 February 2024 (the “Potential Business Combination”).

After careful consideration, the Company and Arkon have determined that the current market conditions are not conducive to proceeding with the Potential Business Combination.

IMPORTANT INFORMATION

This press release may contain information that qualifies or may have qualified as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

DISCLAIMER

This announcement is not for distribution or release, directly or indirectly, and should not be distributed in or sent into, the United States, Australia, Canada, Japan, the Cayman Islands or South Africa or any other jurisdiction in which such distribution or release would be unlawful or would require registration or other measures. This announcement does not contain or constitute an offer of securities for sale or an invitation or offer to the public for securities in any jurisdiction.

In the EEA, this announcement is only directed at persons who are “qualified investors” within the meaning of Article 2(e) of the Prospectus Regulation (EU 2017/1129) as amended. In the United Kingdom, this announcement is directed only at “qualified investors” within the meaning of Article 2(e) of the Prospectus Regulation (EU) No 2017/1129 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

This announcement is not an offer for sale nor a solicitation of an offer to buy any securities in the United States. This announcement is not for distribution, directly or indirectly, in or into the United States. The securities referenced herein have not been and will not be registered under the U.S. Securities Act of 1933 (the “Securities Act”). Securities may not be offered, sold or otherwise transferred within the United States absent registration under the Securities Act or an exemption therefrom. No public offering of the Offer Shares is being made in the United States.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241107765458/en/

Contacts

ENQUIRIES
BM3EAC Corp.
c/o Brigade Capital Management, LP 399 Park Avenue, 16th Floor
New York, NY 10022
Email: BrigadeM3EAC@brigadecapital.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Panini S.p.A. Launches Expanded BioCred Solution Suite in Europe at Future Identity Festival8.11.2024 17:00:00 EET | Press release

Panini S.p.A., a global leader in payments technology and identity solutions, announces the European launch of its BioCred solution suite at Future Identity Festival, in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108392625/en/ Securing the Future, One Identity at a Time. (Photo: Business Wire) BioCred is now available on cloud infrastructure, giving rise to the new BioCred CloudServ, which represents the first step toward a hardware-agnostic solution. As of today, BioCred CloudServ is accessible via the mobile device BioCred SecureTab, the latest addition to the Panini BioCred family of devices, creating a seamlessly integrated flow and delivering a comprehensive, secure identity solution. This turnkey solution, which was presented for the first time at Identity Week America in September, offers a wide range of authentication and verification functions, including the patented Panini BioCred method into a s

ITEN to Launch the Industrial-Scale Production of Its All-Solid-State Battery Powency Product Family8.11.2024 10:00:00 EET | Press release

Electronica 2024 Trade Fair--ITEN, a pioneer in the development and production of solid-state batteries for electronics markets, today announced the production launch of its new Powency family of rechargeable Li-ion batteries. The new family consists of high-power density batteries, including for now the PWY0150S battery, available in pre-production, and the PWY0250S battery, available as engineering samples. Those first Powency batteries respectively have a capacity of 150µAh and 250µAh. The Powency product family, which is manufactured at the ITEN facility in France, is a testament to the demonstration of ITEN's technological and industrial leadership in the field of solid-state batteries. ITEN will participate in the Electronica trade show in Munich from November 12 to 15, 2024 (Hall B4 - Stand E05) to showcase both PWY0150S and PWY0250S. Powency PWY0150S and PWY0250S, solid-state energy storage in an unmatched form factor The Powency PWS0150S and PWS0250S batteries are designed to

FPT Named Disruptor In HFS Horizons: IoT Service Providers, 20248.11.2024 07:53:00 EET | Press release

Global IT firm FPT, through its subsidiary FPT Software, has been recognized as a Disruptor in HFS Research Horizons report: IoT Service Providers, 2024. This marks the inaugural inclusion of FPT in this prestigious industry assessment, demonstrating its Internet of Things (IoT) capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241107263712/en/ (Graphic: Business Wire) The report examines the IoT service capabilities of 23 service providers in the evolving IoT landscape in the age of the Generative Enterprise. It focuses on the supply side, detailing the service providers’ strengths and growth opportunities. FPT’s IoT capabilities encompass a comprehensive range of services designed to address diverse industry needs, from smart homes and healthcare to logistics and manufacturing. With over 3,000 IoT engineers and a portfolio of more than 500 projects, FPT delivers end-to-end IoT solutions, including hardware desig

Analyze Contracts Like a Lawyer - Wordsmith’s First Pass Unlocks Legal Insight for Everyone8.11.2024 00:54:00 EET | Press release

“Contracts often hold up business because legal teams are stretched too thin,” said Ross McNairn, CEO of Wordsmith. “First Pass allows anyone from the legal, commercial or other teams to quickly identify risks and key terms, helping move things forward.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108164624/en/ Wordsmith's First Pass lets you review contracts in minutes, not hours. (Graphic: Business Wire) This is a glimpse at the future of legal AI agents. Taking a very specific task end-to-end and making it trivial for anyone to trigger. Try It for Free Users can access First Pass for free by creating an account at wordsmith.ai and then uploading the relevant agreement to the web, or simply email standard agreements—like NDAs—to nda@wordsmith.ai. Over the coming weeks, Wordsmith will be expanding this to many other agreement types. End-to-End AI Analysis—More Than Just Contracting What makes First Pass revolutionary

Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research7.11.2024 23:01:00 EET | Press release

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it has signed an agreement to acquire the DNA and RNA business of Officinae Bio. The acquisition is expected to expand Maravai and TriLink BioTechnologies' ability to assist customers in developing innovative nucleic acid-based therapies. Based in Venice, Italy, Officinae Bio is a privately held technology company with a proprietary digital platform to support the biological design of therapeutics. The novel technology enables rapid prototyping of mRNA candidates to test diverse combinations of CAP analogs, chemistry modifications, and sequence designs for client discovery programs. Officinae Bio’s portfolio of technology and services complements Maravai’s nucleic acid production services and is expected to provide customers with significant benefits as they bring new and innovative therapies to patients in need. “Officinae Bio’s uniqu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye